Articles > Reference > Dictionaries, Thesauruses, Pictures, and Press Releases > M2 Presswire press releases > July-September 2008 > Monday, September 1

Article: Available Now - Optimer Pharmaceuticals Inc: Premium Company Profile.

Article from:
M2 Presswire
Article date:
September 1, 2008
Copyright

M2 PRESSWIRE-1 September 2008-Research and Markets: Available Now - Optimer Pharmaceuticals Inc: Premium Company Profile(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:01092008

Dublin - Research and Markets (http://www.researchandmarkets.com/research/f0b8df/optimer_pharmaceut) has announced the addition of the "Optimer Pharmaceuticals Inc: Premium Company Profile" companyprofile to their offering.

Optimer is a biopharmaceutical company focused on the discovery, development and global commercialization of anti-infective products for the treatment of serious infectious diseases. The Company currently has two late stage anti-infective product candidates, ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Research and Markets: Available Now - Optimer ...
Business Wire;  September 1, 2008 ;     700+ words ... ... Optimer Pharmaceuticals- Value Chain Analysis Table 15: Optimer Pharmaceuticals- Scorecard Table 16: Optimer Pharmaceuticals- Key Employees Table 17: Optimer Pharmaceuticals - Financial and Operational Overview For more information visit ...

Article: Optimer Pharmaceuticals Receives Production Patent ...
PR Newswire;  April 13, 2009 ;     700+ words ... ... 13 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. announced today that the United ... probability of CDI recurrence. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals to Present at September ...
PR Newswire;  September 3, 2009 ;     654 words ... ... 3 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. today announced that the Company ... days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals Announces Presentations of ...
PR Newswire;  September 2, 2009 ;     700+ words ... ... Results from studies related to Optimer Pharmaceuticals, Inc.'s lead developmental product ... number: D-1433 in Hall B About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals to Present at June 2009 ...
PR Newswire;  June 4, 2009 ;     598 words ... ... June 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. today announced that the Company ... days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals to Present at the Canaccord ...
PR Newswire;  August 4, 2009 ;     558 words ... ... 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. is scheduled to present at ... days following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a biopharmaceutical company ...

Article: Optimer Pharmaceuticals to Present at the Cowen and ...
Biotech Week;  March 25, 2009 ;     700+ words ...Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ... Eastern Time (see also Optimer Pharmaceuticals, Inc.). A live audio ... following the meeting. About Optimer Pharmaceuticals Optimer Pharmaceuticals ...

Article: Optimer Pharmaceuticals Announces Publication in ...
Women's Health Weekly;  March 12, 2009 ;     700+ words ...Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ... causing pathogens (see also Optimer Pharmaceuticals, Inc.). Infectious diarrhea ... announced in July 2008. About Optimer Pharmaceuticals Optimer Pharmaceuticals ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives